Do Not Switch to NP Thyroid
You should not switch your patient from levothyroxine 75 mcg to NP Thyroid (desiccated thyroid extract), as major clinical practice guidelines explicitly recommend against using desiccated thyroid hormone for the treatment of hypothyroidism. 1
Guideline-Based Recommendation
The 2012 AACE/ATA Clinical Practice Guidelines provide a clear, unanimous expert opinion stating: "There is no evidence to support using desiccated thyroid hormone in preference to L-thyroxine monotherapy in the treatment of hypothyroidism and therefore desiccated thyroid hormone should not be used for the treatment of hypothyroidism" (Grade D, BEL 4). 1
Key Reasons Against Switching:
Variable hormone content and ratios: Desiccated thyroid preparations contain a T4:T3 ratio of approximately 4:1 by weight, which differs significantly from the physiologic ratio produced by the human thyroid gland. 1 The content of thyroid hormone and the T4:T3 ratio may vary depending on the brand employed and whether it is of porcine or bovine origin. 1
Lack of systematic study: Desiccated thyroid has not been systematically studied, making its safety and efficacy profile poorly characterized compared to levothyroxine. 1
No demonstrated superiority: A 2024 systematic review found that two RCTs could not demonstrate any difference in quality of life or symptom scores when comparing desiccated thyroid extract with levothyroxine, and most studies are hampered by inferior design with lacking data on long-term effects and side effects. 2
Clinical Considerations
If Patient Requests the Switch:
While nearly half of patients in one crossover study expressed preference for desiccated thyroid extract (48.6%), this preference was associated with modest weight loss (3-4 lbs) rather than objective improvements in neurocognitive function or validated symptom measures. 3 Weight loss alone is not a medically appropriate indication for switching thyroid hormone preparations.
Potential Risks of Desiccated Thyroid:
- Cardiovascular effects: May cause increased heart rate and alterations in lipid profiles 2
- Supraphysiologic T3 levels: The higher T3 content can lead to transient hyperthyroid symptoms
- Inconsistent potency: Variable hormone content between batches and brands 1
Alternative Approach
If your patient is experiencing persistent symptoms despite adequate TSH control on levothyroxine 75 mcg:
Verify TSH is at goal (typically 0.5-2.5 mIU/L for most patients) with testing 4-8 weeks after any dose adjustment 1
Check for absorption issues: Ensure levothyroxine is taken 30-60 minutes before breakfast or 4 hours after the last meal, away from interfering substances (iron, calcium, antacids) 1, 4
Consider alternative levothyroxine formulations: If absorption or tolerance is an issue, liquid formulations of levothyroxine may be better tolerated 5
Evaluate for other causes of symptoms: Many symptoms attributed to hypothyroidism may have alternative etiologies requiring separate evaluation
Common Pitfall to Avoid
Do not switch formulations based solely on patient preference or anecdotal reports without medical indication. The guideline recommendation against desiccated thyroid is based on lack of evidence for benefit and potential for harm, not simply tradition. 1